AUPH — Aurinia Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual balance sheet for Aurinia Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	306	398	466	389	350
Net Total Accounts Receivable
Net Total Receivables	0.368	1.02	15.4	13.5	24.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	315	419	513	443	425
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.093	10.3	9.8	8.56	117
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	324	464	543	471	548
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.3	32	40.6	46.1	77.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	25.7	55.9	64.3	65.4	170
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	299	408	479	405	378
Total Liabilities & Shareholders' Equity	324	464	543	471	548
Total Common Shares Outstanding